BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32267918)

  • 1. Early protein expression profile in bronchoalveolar lavage fluid and clinical outcomes in primary graft dysfunction after lung transplantation.
    Frick AE; Verleden SE; Ordies S; Sacreas A; Vos R; Verleden GM; Vanaudenaerde BM; Claes S; Schols D; Van Raemdonck DE; Neyrinck AP
    Eur J Cardiothorac Surg; 2020 Aug; 58(2):379-388. PubMed ID: 32267918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
    Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation.
    Geube MA; Perez-Protto SE; McGrath TL; Yang D; Sessler DI; Budev MM; Kurz A; McCurry KR; Duncan AE
    Anesth Analg; 2016 Apr; 122(4):1081-8. PubMed ID: 26991618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation.
    Xu Z; Sharma M; Gelman A; Hachem R; Mohanakumar T
    J Heart Lung Transplant; 2017 Mar; 36(3):331-339. PubMed ID: 27773452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation.
    Verleden SE; Martens A; Ordies S; Neyrinck AP; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Clin Transplant; 2018 Apr; 32(4):e13219. PubMed ID: 29405435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
    J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
    Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
    Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lung microbiota in primary graft dysfunction in lung transplant recipients.
    Wu Y; Huang L; Li M; Cui X; Zhan Q; Wang C
    Clin Transplant; 2023 Dec; 37(12):e15152. PubMed ID: 37788167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lung Allograft Microbiome Associates with Pepsin, Inflammation, and Primary Graft Dysfunction.
    McGinniss JE; Whiteside SA; Deek RA; Simon-Soro A; Graham-Wooten J; Oyster M; Brown MD; Cantu E; Diamond JM; Li H; Christie JD; Bushman FD; Collman RG
    Am J Respir Crit Care Med; 2022 Dec; 206(12):1508-1521. PubMed ID: 36103583
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelial Glycocalyx Shedding Predicts Donor Organ Acceptability and Is Associated With Primary Graft Dysfunction in Lung Transplant Recipients.
    Sladden TM; Yerkovich S; Grant M; Zhang F; Liu X; Trotter M; Hopkins P; Linhardt RJ; Chambers DC
    Transplantation; 2019 Jun; 103(6):1277-1285. PubMed ID: 30444804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantation.
    Somers J; Ruttens D; Verleden SE; Vandermeulen E; Piloni D; Wauters E; Lambrechts D; Vos R; Verleden GM; Vanaudenaerde B; van Raemdonck DE
    J Heart Lung Transplant; 2015 Jul; 34(7):941-9. PubMed ID: 25935436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interleukin 8 concentrations in donor bronchoalveolar lavage: impact on primary graft failure in double lung transplant].
    Almenar M; Cerón J; Gómez MA; Peñalver JC; Jiménez MA; Padilla J
    Arch Bronconeumol; 2009 Jan; 45(1):12-5. PubMed ID: 19186293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe primary graft dysfunction of the heart transplant is associated with increased plasma and intragraft proinflammatory cytokine expression.
    Holmström EJ; Syrjälä SO; Dhaygude K; Tuuminen R; Krebs R; Nykänen A; Lemström KB
    J Heart Lung Transplant; 2023 Jun; 42(6):807-818. PubMed ID: 36754701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
    Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
    Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
    J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.
    Abbas AA; Diamond JM; Chehoud C; Chang B; Kotzin JJ; Young JC; Imai I; Haas AR; Cantu E; Lederer DJ; Meyer KC; Milewski RK; Olthoff KM; Shaked A; Christie JD; Bushman FD; Collman RG
    Am J Transplant; 2017 May; 17(5):1313-1324. PubMed ID: 27731934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant endothelin-1 overexpression in lung transplant donors and recipients predicts primary graft dysfunction.
    Salama M; Andrukhova O; Hoda MA; Taghavi S; Jaksch P; Heinze G; Klepetko W; Aharinejad S
    Am J Transplant; 2010 Mar; 10(3):628-36. PubMed ID: 20055806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.
    Sayah DM; Mallavia B; Liu F; Ortiz-Muñoz G; Caudrillier A; DerHovanessian A; Ross DJ; Lynch JP; Saggar R; Ardehali A; ; Ware LB; Christie JD; Belperio JA; Looney MR
    Am J Respir Crit Care Med; 2015 Feb; 191(4):455-63. PubMed ID: 25485813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
    DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.